Use of MID-NET in PMS Could Promote Comparisons of One’s Own Products with Other Treatments: FPMAJ Official

Kotonari Aoki Use of the Pharmaceuticals and Medical Devices Agency’s large-scale medical database (MID-NET) in drug makers’ post-marketing surveillance (PMS) will promote comparisons with other treatments as a means for companies to confirm the safety of their own products in...read more